Enphase Energy a company exhibitor seen at the Bepositive Energy ... More Transition Show. (Photo by Romain Doucelin/SOPA ...

Despite Nektar’s share price shooting up as much as 175% on Tuesday, William Blair maintained that “there is an absence of ...

NKTR shares climb to $9.54 amid investor optimism and Phase IIb REZOLVE-AD results; EPS forecasts up 10.5% in 30 days.

US Dollar South African Rand, Nasdaq 100, S&P 500, Alphabet Inc Class A. Read 's Market Analysis on Investing.com ZA.

The European Union plans to impose retaliatory tariffs on US imports, including on Boeing Co. aircraft, if President Donald ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

The agency said it will evaluate whether further regulatory action is needed after investigating the deaths of two patients ...

Major indices closed higher on Tuesday despite Israeli claims that Iran had already breached a ceasefire agreement.

NKTR stock is up around 150% in today’s trading session following the recently announced positive results from its Phase 2b ...

Nektar Therapeutics said on Tuesday its lead drug candidate met the main goal of a mid-stage study testing the drug in eczema patients, sending its shares up by nearly 140%. In the 393-patient global ...

Shares of Nektar Therapeutics (NKTR) more than doubled on Tuesday afternoon after the company announced that its mid-stage ...

The U.S. current account deficit increased by 44.3% to $450.2 billion in the first quarter versus a revised deficit of $312 billion in the fourth quarter and compared to market estimates of a $443.3 ...